U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07639073) titled 'Low-Dose Versus Conventional-Dose Oral Isotretinoin for Acne Vulgaris' on June 05.
Brief Summary: Background and Purpose:
Acne vulgaris is a common skin condition that can cause significant physical and emotional distress. Oral isotretinoin is a highly effective treatment for severe or persistent acne. While the standard (conventional) dose is effective, it is often associated with side effects like dry skin, chapped lips, and altered labs.
The purpose of this study is to compare a lower daily dose of oral isotretinoin against the conventional daily dose in individuals with acne vulgaris.
What the Study Aims to Find Out:
Researc...